raisonance

RAIsonance's new AI-powered app supports the healing journey of Long COVID and Post COVID Condition sufferers

RAIsonance, Inc., formally launches its innovative mobile app: MyAdvocate LC/PCC.

18 October 2023

RAIsonance Launches the Air Quality Human Impact Program

RAIsonance is recruiting users to join its Air Quality Human Impact Program to track the impact of poor air quality on the human respiratory system

29 August 2023

Raisonance Releases New Fall 2023 Workforce Risk Forecast

RAIsonance has released its Fall 2023 Workforce Wellness Risk Forecast Report, offering evidence-based insights into potential health risks for the upcoming season, aiding employers in preparing for and mitigating productivity disruptions from contagious illnesses in the...

21 August 2023

RAIsonance, Inc. Announces BARDA Contract to Continue Development of the AudibleHealth Dx Diagnostic SaMD for COVID-19 and Influenza Through AI-Powered Cough Analysis

RAIsonance’s Forced Cough Vocalization (FCV) Signature Analysis Technology is Designed to Diagnose Respiratory Illnesses Via a Cloud-Based Diagnostic Platform and a Mobile App User Interface

12 April 2023

RAIsonance, Inc. Launches AI-Powered Smoker Recovery App

MyAdvocate Product Tracks Progress Upon Quitting and Delivers a Personalized Biometric Score for Each User’s Respiratory Wellness Journey

11 April 2023

Vaping in Schools: RAIsonance and Soter Technologies Partner to Enhance Cessation

MyAdvocate, AI Cough Analysis Technology to Help Young People Quit Harmful Smoking and Vaping Habit

23 March 2023

RAIsonance announces beta of MyAdvocate app for Long COVID sufferers

RAIsonance Inc. announces the beta testing phase of its innovative, AI-powered tracker for sufferers of Long COVID. Part of the MyAdvocate line of Forced Cough Vocalization (FCV) wellness products, this platform was specially developed to track the unique and complex sym...

21 March 2023

RAIsonance Develops FCV Signature Analysis Technology for Health, Wellness

AI-Powered Innovation using Forced Cough Vocalization

13 March 2023

RAIsonance Announces Executive Leadership Appointments

RAIsonance, Inc., a group of Artificial Intelligence – Machine Learning (AI-ML) technology solutions companies, today announced the promotion of Paul McLenaghan to Chief Revenue Officer and the hiring of Kris Hopkins as Chief Product Officer.

14 February 2023

RAIsonance Submits EUA Application to FDA for AudibleHealth Dx

RAIsonance, Inc., today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of its AudibleHealth Dx Software as a Medical Device (SaMD). The device is designed to analyze a user’s Forced Coug...

26 September 2022